Fibromyalgia - 5EU Drug Forecast and Market Analysis to 2023
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
eturn<br />
Stay ahead of the competition by underst<strong>and</strong>ing the changing competitive l<strong>and</strong>scape for<br />
<strong>Fibromyalgia</strong>.<br />
Effectively plan your M&A <strong>and</strong> partnership strategies by identifying drugs with the most<br />
promising sales potential<br />
Make more informed business decisions from insightful <strong>and</strong> indepth analysis of drug<br />
performance<br />
Obtain sales forecast for drugs from 2013<strong>2023</strong> in <strong>5EU</strong>.<br />
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreportsbiz<br />
Table of Contents<br />
1 Table of Contents<br />
1 Table of Contents 2<br />
1.1 List of Tables 5<br />
1.2 List of Figures 7<br />
2 Introduction 8<br />
2.1 Catalyst 8<br />
2.2 Related Reports 8<br />
2.3 Upcoming Related Reports 9<br />
3 Disease Overview 10<br />
3.1 Etiology <strong>and</strong> Pathophysiology 10<br />
3.1.1 Etiology 10<br />
3.1.2 Pathophysiology 12<br />
3.2 Classification 16<br />
3.3 Symp<strong>to</strong>ms 16<br />
3.4 Quality of Life 17<br />
4 Disease Management 18<br />
4.1 Diagnosis <strong>and</strong> Treatment Overview 18<br />
4.1.1 Diagnosis 18<br />
4.1.2 Treatment Guidelines <strong>and</strong> Leading Prescribed <strong>Drug</strong>s 20<br />
4.1.3 Clinical Practice 22<br />
4.2 France 24<br />
4.3 Germany 25<br />
4.4 Italy 27<br />
4.5 Spain 29<br />
4.6 UK 31<br />
5 Competitive Assessment 34<br />
5.1 Overview 34<br />
5.2 Product Profiles 35<br />
5.2.1 Cymbalta (duloxetine) 35<br />
5.2.2 Savella (milnacipran) 39<br />
5.2.3 Lyrica (pregabalin) 44<br />
5.2.4 Neurontin (gabapentin) 49<br />
About us<br />
<strong>Market</strong>ResearchReports.biz is the most comprehensive collection of market research
Change language